Investing Profile

Rajeev Dadoo

Photo of Rajeev Dadoo, Partner at SR One

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
511 CONNECTIONS
cb
SR One Partner
8
CompanyStageDateRound SizeTotal Raised
Renalys Pharma
Series AJul 2024$38M
$38M
Nimbus Therapeutics
Private EquitySep 2023$210M
$640M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Bruce Booth (Atlas Venture), Laura Stoppel (RA Capital), Peter Kolchinsky (RA Capital), Nikola Trbovic (Pfizer Venture Investments), Vicki Sato (ARCH Venture Partners), Bill Gates
Dren Bio
Series BJun 2022$65M
Series AOct 2020$60M
$130M
Co-investors: Sakae Asanuma (Taiho Ventures), Andrew Schiff (Aisling Capital)
ARS Pharmaceuticals
Series DAug 2021$55M
$55M
Co-investors: Peter Kolchinsky (RA Capital)
Tranquis Therapeutics
Series AJul 2020$30M
$30M
Co-investors: Edgar Engleman (Vivo Capital), Taro Inaba (Remiges Ventures)
iPierian
Series UnknownSep 2013$30M
Series BNov 2010$29M
$83M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Martin Alexander Gershon (Endeavor Venture Funds), Jim Scopa (MPM Capital), Beth Seidenberg (Westlake Village BioPartners), Wesley Chan (FPV Fund)
Partner SR One2004 - Present
Knox College BA
Stanford University PhD
The Wharton School/Univ. Penn MBA